FDA clears 1st blood test for Alzheimer’s in primary care

Ella Jeffries / beckershospitalreview - The first FDA-cleared blood test to assess Alzheimer’s disease in primary care is now available for patients age 55 and older with symptoms of cognitive decline. The test aims to help clinicians rule out Alzheimer’s by identifying individuals unlikely to …

AI Summary: Regulators cleared the first blood test for Alzheimer’s for primary‑care use while researchers published capillary sampling methods and analyses showing blood biomarkers’ promise for dementia diagnosis. Together these developments push biomarker testing out of specialty clinics and toward routine care — promising earlier detection, though concerns about population diversity, accuracy thresholds and rollout logistics remain.

#healthcare #publichealth #governmentpolicy #biotech #fda

A possible Alzheimer's biomarker? Why REST protein levels are drawing attention

3 months / medicalxpress

J&J pauses patient recruitment in mid-stage trial of AC Immune’s Alzheimer’s drug

3 months / endpoints / Elizabeth Cairns

Blood test 'clocks' can predict when Alzheimer's symptoms will start

3 months / medicalxpress

Viagra and shingles vaccine show surprising promise against Alzheimer’s

3 months / sciencedaily

Paragon's new biotech Korsana tackles Alzheimer's like Roche

3 months / endpoints / Kyle LaHucik

Air pollution may directly contribute to Alzheimer's disease